PROCEPT BioRobotics Corporation Common Stock (NASDAQ: PRCT) last traded at $18.40, up 2.79% on the session. The quote above updates while this page is open; the figures below are drawn from PROCEPT BioRobotics Corporation Common Stock’s own filings and are restated only when a new one is published.
PROCEPT BioRobotics Corporation Common Stock trades on NASDAQ under the ticker PRCT. Its market capitalisation is $1.05 billion.
Valuation measures for PROCEPT BioRobotics Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.05B |
|---|---|
| Enterprise value | $965.20M |
| Price / sales | 3.12 |
| Price / book | 3.10 |
| Beta | 0.75 |
Trailing-twelve-month figures tagged in PROCEPT BioRobotics Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $337.34M |
|---|---|
| Net income (TTM) | -$109.76M |
| EPS (TTM) | -$1.95 |
| Gross margin | 64.22% |
| Operating margin | -33.86% |
| Return on equity | -32.27% |
| Cash | $227.91M |
Range and volume for PRCT over the past 52 weeks.
| 52-week high | $38.11 |
|---|---|
| 52-week low | $16.67 |
| Volume | 1.11M |
| Average volume | 1.43M |
| Previous close | $17.90 |
Invest a chosen dollar amount in PROCEPT BioRobotics Corporation Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PRCT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.